117 related articles for article (PubMed ID: 31288177)
1. Long-term follow-up and safety assessment of angiogenic gene therapy trial VIF-CAD: Transcatheter intramyocardial administration of a bicistronic plasmid expressing VEGF-A165/bFGF cDNA for the treatment of refractory coronary artery disease.
Kukuła K; Urbanowicz A; Kłopotowski M; Dąbrowski M; Pręgowski J; Kądziela J; Chmielak Z; Witkowski A; Rużyłło W
Am Heart J; 2019 Sep; 215():78-82. PubMed ID: 31288177
[TBL] [Abstract][Full Text] [Related]
2. Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD).
Kukuła K; Chojnowska L; Dąbrowski M; Witkowski A; Chmielak Z; Skwarek M; Kądziela J; Teresińska A; Małecki M; Janik P; Lewandowski Z; Kłopotowski M; Wnuk J; Rużyłło W
Am Heart J; 2011 Mar; 161(3):581-9. PubMed ID: 21392615
[TBL] [Abstract][Full Text] [Related]
3. NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study.
Gyöngyösi M; Khorsand A; Zamini S; Sperker W; Strehblow C; Kastrup J; Jorgensen E; Hesse B; Tägil K; Bøtker HE; Ruzyllo W; Teresiñska A; Dudek D; Hubalewska A; Rück A; Nielsen SS; Graf S; Mundigler G; Novak J; Sochor H; Maurer G; Glogar D; Sylven C
Circulation; 2005 Aug; 112(9 Suppl):I157-65. PubMed ID: 16159809
[TBL] [Abstract][Full Text] [Related]
4. High-dose plasmid-mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial.
Favaloro L; Diez M; Mendiz O; Janavel GV; Valdivieso L; Ratto R; Garelli G; Salmo F; Criscuolo M; Bercovich A; Crottogini A
Catheter Cardiovasc Interv; 2013 Nov; 82(6):899-906. PubMed ID: 22777825
[TBL] [Abstract][Full Text] [Related]
5. Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease--12-month follow-up: angiogenic gene therapy.
Sarkar N; Rück A; Källner G; Y-Hassan S; Blomberg P; Islam KB; van der Linden J; Lindblom D; Nygren AT; Lind B; Brodin LA; Drvota V; Sylvén C
J Intern Med; 2001 Nov; 250(5):373-81. PubMed ID: 11887971
[TBL] [Abstract][Full Text] [Related]
6. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.
Kastrup J; Jørgensen E; Rück A; Tägil K; Glogar D; Ruzyllo W; Bøtker HE; Dudek D; Drvota V; Hesse B; Thuesen L; Blomberg P; Gyöngyösi M; Sylvén C;
J Am Coll Cardiol; 2005 Apr; 45(7):982-8. PubMed ID: 15808751
[TBL] [Abstract][Full Text] [Related]
7. A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial.
Kastrup J; Jørgensen E; Fuchs S; Nikol S; Bøtker HE; Gyöngyösi M; Glogar D; Kornowski R
EuroIntervention; 2011 Feb; 6(7):813-8. PubMed ID: 21252014
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up assessment of a phase 1 trial of angiogenic gene therapy using direct intramyocardial administration of an adenoviral vector expressing the VEGF121 cDNA for the treatment of diffuse coronary artery disease.
Rosengart TK; Bishawi MM; Halbreiner MS; Fakhoury M; Finnin E; Hollmann C; Shroyer AL; Crystal RG
Hum Gene Ther; 2013 Feb; 24(2):203-8. PubMed ID: 23137122
[TBL] [Abstract][Full Text] [Related]
9. VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial.
Stewart DJ; Kutryk MJ; Fitchett D; Freeman M; Camack N; Su Y; Della Siega A; Bilodeau L; Burton JR; Proulx G; Radhakrishnan S;
Mol Ther; 2009 Jun; 17(6):1109-15. PubMed ID: 19352324
[TBL] [Abstract][Full Text] [Related]
10. Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer.
Hedman M; Muona K; Hedman A; Kivelä A; Syvänne M; Eränen J; Rantala A; Stjernvall J; Nieminen MS; Hartikainen J; Ylä-Herttuala S
Gene Ther; 2009 May; 16(5):629-34. PubMed ID: 19212427
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease.
Fuchs S; Dib N; Cohen BM; Okubagzi P; Diethrich EB; Campbell A; Macko J; Kessler PD; Rasmussen HS; Epstein SE; Kornowski R
Catheter Cardiovasc Interv; 2006 Sep; 68(3):372-8. PubMed ID: 16892433
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor gene transfer therapy for coronary artery disease: A systematic review and meta-analysis.
Yuan R; Xin Q; Shi W; Liu W; Lee SM; Hoi P; Li L; Zhao J; Cong W; Chen K
Cardiovasc Ther; 2018 Oct; 36(5):e12461. PubMed ID: 30035366
[TBL] [Abstract][Full Text] [Related]
13. PET for evaluation of differential myocardial perfusion dynamics after VEGF gene therapy and laser therapy in end-stage coronary artery disease.
Tio RA; Tan ES; Jessurun GA; Veeger N; Jager PL; Slart RH; de Jong RM; Pruim J; Hospers GA; Willemsen AT; de Jongste MJ; van Boven AJ; van Veldhuisen DJ; Zijlstra F
J Nucl Med; 2004 Sep; 45(9):1437-43. PubMed ID: 15347709
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
[TBL] [Abstract][Full Text] [Related]
15. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia.
Losordo DW; Vale PR; Hendel RC; Milliken CE; Fortuin FD; Cummings N; Schatz RA; Asahara T; Isner JM; Kuntz RE
Circulation; 2002 Apr; 105(17):2012-8. PubMed ID: 11980678
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF.
Hughes GC; Biswas SS; Yin B; Coleman RE; DeGrado TR; Landolfo CK; Lowe JE; Annex BH; Landolfo KP
Ann Thorac Surg; 2004 Mar; 77(3):812-8. PubMed ID: 14992878
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of long-term clinical efficacy with catheter-based percutaneous intramyocardial autologous bone marrow cell implantation versus laser myocardial revascularization in patients with severe coronary artery disease.
Tse HF; Thambar S; Kwong YL; Rowlings P; Bellamy G; McCrohon J; Bastian B; Chan JK; Lo G; Ho CL; Parker A; Hauser TH; Lau CP
Am Heart J; 2007 Nov; 154(5):982.e1-6. PubMed ID: 17967607
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy in cardiac surgery: intramyocardial injection of naked plasmid DNA for chronic myocardial ischemia.
Heilmann CA; Attmann T; Thiem A; Haffner E; Beyersdorf F; Lutter G
Eur J Cardiothorac Surg; 2003 Nov; 24(5):785-93. PubMed ID: 14583313
[TBL] [Abstract][Full Text] [Related]
19. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.
Losordo DW; Schatz RA; White CJ; Udelson JE; Veereshwarayya V; Durgin M; Poh KK; Weinstein R; Kearney M; Chaudhry M; Burg A; Eaton L; Heyd L; Thorne T; Shturman L; Hoffmeister P; Story K; Zak V; Dowling D; Traverse JH; Olson RE; Flanagan J; Sodano D; Murayama T; Kawamoto A; Kusano KF; Wollins J; Welt F; Shah P; Soukas P; Asahara T; Henry TD
Circulation; 2007 Jun; 115(25):3165-72. PubMed ID: 17562958
[TBL] [Abstract][Full Text] [Related]
20. Myocardial Doppler tissue velocity improves following myocardial gene therapy with VEGF-A165 plasmid in patients with inoperable angina pectoris.
Sylvén C; Sarkar N; Rück A; Drvota V; Hassan SY; Lind B; Nygren A; Källner Q; Blomberg P; van der Linden J; Lindblom D; Brodin LA; Islam KB
Coron Artery Dis; 2001 May; 12(3):239-43. PubMed ID: 11352080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
